CTOs on the Move

Dracen Pharmaceuticals

www.dracenpharma.com

 
Dracen is a privately funded biotech company developing drugs in the area in of immuno metabolism.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.dracenpharma.com
  • 1812 Ashland and Avenue 1st Floor, Suite 100
    Baltimore, MD USA 21205
  • Phone: 917.398.3710

Executives

Name Title Contact Details

Funding

Dracen Pharmaceuticals raised $40M on 03/22/2018

Similar Companies

HearingLife

HearingLife offers hearing wellness care and hearing aids for people who want to achieve optimal results. For a free hearing assessment call (844) 836-5003.

Amador Bioscience

Amador Bioscience, a leading partner for successful new drug development, provides global-standard translational sciences and clinical pharmacology services to clients ranging from cutting-edge biotech start-ups to multinational pharmaceutical companies. Founded in 2018 and supported by prominent institutional investors, Amador Bioscience operates in multiple sites, Pleasanton, CA, Ann Arbor, MI, Germantown, MD, Richmond, VA, Hangzhou and Shanghai, China, and Limburg.

Niadyne

Niadyne is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Concord

Concord is a Atlanta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Ancillare

Ancillary Supply Chain, Simplified Ancillare is the leader in end-to-end global clinical trial ancillary supply chain management needs of large- and middle-market pharmaceutical, biotechnology, and medical device companies, as well as contract and medical research organizations. Ancillare is the first organization of its kind with an exclusive focus on the global clinical trial ancillary supply chain. Ancillare arms sponsors of global clinical trials with a customized, end-to-end Ancillare Supply Plan, enabling developers of new therapies to optimize their clinical study supply chains using streamlined processes, extensive global buying power, a vast depot network and proven teams of clinical, procurement, operations, logistics, and regulatory experts. Ancillare`s Turn-Key Operations (A-TKO™) model embraces the complexities and globalization of the clinical and ancillary supply chain by reducing both the overall cost and cycle time of clinical trials, and greatly improving operational efficiency across all levels of the value chain. Ancillare has supported more than 1,500 clinical trials across 80,000 clinical sites over 100 countries with master depots in United States, United Kingdom, and Singapore, and strategic depots in Argentina, Australia, Brazil, Canada, Chile, China, Colombia, India, Israel, Japan, Korea, Mexico, Panama, Peru, Philippines, Russia, South Africa, Taiwan, and Ukraine.